Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conferenceseries: World’s leading Event Organizer

Conference Series Conferences gaining more Readers and Visitors

Conference Series Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Oncogenesis 2018

About Conference


International Conference on Oncogenesis and Oncologic Emergency Medicine, September 17-18, 2018 San Diego, USA hosted by Conferences Series. Through the theme "Research Innovation and Navigating the Cancer Care", conference will explore the advances in Oncology, Cancer Therapeutics, Medical Approaches, Translational Oncology, Computational Technologies, etc. This conference brings a novel and International mixture of giant and medium cancer therapeutics and oncology, leading universities and cancer analysis establishments creating the conference an excellent platform to share expertise, foster collaborations across trade and world and assess rising technologies across the world.

Conference Series Organizes 1000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 50000 eminent personalities, reputed scientists as editorial board members. To know more about the conference series visit: http://conferenceseries.com/

Who Should Attend

The Oncogenesis 2018, San Diego, USA offers a platform for the Oncologists and experts both from Industry and Academia working in various sub domains of Oncology ranging from classical Oncology to the advanced technologies and image analysis in Oncology including Oncological Diagnosis and therapy.

Professionals from Oncological Laboratories, Hospitals, and Academics:-

Directors, Deans, Research Professionals, Laboratory heads, Lab managers, Lab technicians, Laboratory Professionals, Medical, Biomedical scientists, Professors, Associate Professors, Assistant Professors, Research Practicing pathologist, Research Fellows, Medical students, Residents, working in the arena of Oncology and its allied fields, Medical oncologists, Chemotherapy, Surgical oncologists, Biopsies, Radiation oncologists -  Radiation therapy, Diagnostic Radiologist, Oncology nurse, Oncology social worker and many more.

Industry partners and professionals related to Oncology :-

Oncology, Diagnostic Devices, Imaging Products, Oncology Lab Equipment manufacturers Commercial Diagnostics laboratories, Clinical Research Organizations (CRO), Lab reagents, Assays and Kits suppliers, Oncology service providers etc., Leading companies with Clinical laboratory/ Oncology Services, Genomic Health, Bio-Reference Laboratories which includes like Alere, Laboratory Corporation of America, Myriad Genetics, NeoGenomics, Quest Diagnostics, Siemens Healthineers, Sonic Healthcare Limited, Spectra Laboratories, SYNLAB International GMBH.

Why to attend Oncogenesis 2018?

The Oncogenesis 2018 brings together oncology professionals from around the world to discuss state-of-the-art treatment modalities, new therapies, and ongoing controversies in the field

  • Best platform to develop new partnership and collaborations.
  • Sharpen your skills and become a expert to their particular field.
  • Best location to speed up your route into every territory in the World.
  • Gain new ideas, tools and tactics.
  • Conferences are great way to refuel yourself and chances to shine.
  • 90% our conference attendees are the Key contact in their labs purchasing decisions.
  • Our exhibitor booths were visited 4-5 times by 80% of the attendees during the conference.
  • Network development with both Academia and Business.

 

Sessions/Tracks

1 . Oncology

Oncology is a branch of medication which deals with treatment of tumors. A medically skilled individual who practices oncology is an oncologist. The responsibility of an oncologist is to diagnose, educate and treat patients affected with cancer. The three major areas under the discipline of medical specialty are Surgical, Medical and Radiation. Medical Oncologists are skillful in carrying out treatments which use therapy medication to kill cancer cells and condense the dimensions of tumors. Surgical Oncologists specialize on victimisation surgery to eradicate cancerous tumours and infrequently a margin of healthy tissue encompassing the tumor. Radiation Oncologists are knowledgeable in treating cancer with radiotherapy, that kill cancer cells victimisation numerous radiation machines. The opposite styles of oncologists embrace gynaecological Oncologists, paediatric oncologists and hematologists. Gynaecological Oncologists specialise in treating ladies with cancers like female internal reproductive organ or cervical cancer. Paediatric Oncologists young ones affected with cancer sometimes even below the age of eighteen. A haematologist medical specialist could also be a doctor who treats blood cancer like malignant neoplastic disease.

  • Medical Oncology
  • Surgical Oncology
  • Radiation Oncology
  • Pediatric Oncology
  • Gynecologic Oncology
  • Urologic Oncology
  • Hematology-Oncology

Related Conferences ASCO Annual Meeting 2018, June 1-5, 2018 McCormick Place, Chicago, USA. AACR Annual Meeting 2018 April 14-18, 2018 McCormick Place, Chicago, USA. 5th Annual Meeting of the Japan Society of Clinical Oncology (JSCO) October 20 -22, Pacific Yokohama, Japan. The 76th Annual Meeting of the Japanese Cancer Associationhttps, September 28-30, Pacific Yokohama, Japan. 12th World Congress on Biomarkers & Clinical Research, October 03-04, 2018, Los Angeles, California, USA. 3rd Oncologist & Cancer Diagnostics Conference 2018, September 20-21, 2018 Berlin, Germany. 4th Annual Conference on Preventive Oncology July 18-19, 2018 Atlanta, USA. 27th International Conference on Cancer Research and Anticancer Therapies September 17-18, 2018 San Diego, USA. 2nd International Conference on Cancer Biology and Drug Delivery October 03-04, 2018 Los Angeles, California, USA. International Conference on Gynecology and Obstetrics Pathology March 30-31, 2018 Orlando, USA.

2 . Clinical Oncology

Clinical medical specialty enfolds the non-surgical side of medical specialty. 85th of all clinical oncologists treat patients with a balance of therapy and action therapy. Clinical oncologists are concerned with the treatment of all kinds of cancer. They work intently in massive multidisciplinary groups that specialize in the treatment of cancer poignant components of the body or systems. They treat patients and manage their cancer throughout the span of illness. This specialty offers the chance of developing clinical and scientific skills with nice potential for educational and clinical analysis. Technologies within the field of clinical oncology square measure up promptly. For instance, some tumor’s will be treated with extremely subtle exactitude external beam radiation, like nucleon beam therapy. Some patients will be cured, except for others the stress is on effective palliative care and up quality of life.

  • Clinical Oncologists
  • Non-surgical Oncology
  • Clinical trials
  • Cancer Biology

Related Conferences 2nd World Congress on Nursing & Nurse Education, Nov 20 - 22, 2017, Miami, Florida, USA, EONS Leadership Summit, Sunday 19 November and Monday 20 November 2017, Cancer Care - Coming of Age Considerations for older people during and beyond cancer Creswick, VIC, November 24, 2017. 42nd Annual Conference and Exhibit, September 13-15, 2018, Savannah, GA. International Conference on Cancer Nursing (ICCN) 2018 will be held from September 23-26, 2018, Auckland New Zealand. 26th Annual Congress on Cancer Science and Therapy October 03-04, 2018 Los Angeles, California, USA. 4th Annual Conference on Preventive Oncology July 18-19, 2018 Atlanta, USA. 27th International Conference on Cancer Research and Anticancer Therapies September 17-18, 2018 San Diego, USA. 2nd International Conference on Cancer Biology and Drug Delivery October 03-04, 2018 Los Angeles, California, USA. International Conference on Gynecology and Obstetrics Pathology March 30-31, 2018 Orlando, USA.

3 . Radiation Oncology

Radiation medical specialty embraces all aspects of analysis which influences the treatment of cancer using radiation. The sphere of radiation medical specialty covers the admixure of actinotherapy into multimodal treatment approaches. External beam radiation is delivered outside the body. This includes leading high-energy radiation beams at the area being targeted among the body victimisation varied radiation machines. Brachytherapy is radiation applied directly into the target. It is extremely effective as the radiation is focused on the target diseased site instead of healthy closed organs. Radioimmunotherapy (RIT) uses protein with specificity for a growth- associated substance tagged with a radionuclide to deliver cytotoxic radiation to a tumor cell. General actinotherapy uses radioactive medication to treat cancer consistently, within which the radioactive substance travels through the blood stream to achieve cells inside the body

  • Radiation physics
  • External beam radiation therapy
  • Brachytherapy and Radio immunotherapy
  • Systemic radiation therapy
  • Cancer imaging
  • Palliative Medicine

Related Conferences AACR Annual Meeting 2018 April 14-18, 2018 McCormick Place, Chicago, USA. 5th Annual Meeting of the Japan Society of Clinical Oncology (JSCO) October 20 -22, Pacific Yokohama, JapanThe 76th Annual Meeting of the Japanese Cancer Associationhttps, September 28-30, Pacific Yokohama, Japan. 12th World Congress on Biomarkers & Clinical Research, October 03-04, 2018, Los Angeles, California, USA. 3rd Oncologist & Cancer Diagnostics Conference 2018, September 20-21, 2018 Berlin, Germany4th Annual Conference on Preventive Oncology July 18-19, 2018 Atlanta, USA. 27th International Conference on Cancer Research and Anticancer Therapies September 17-18, 2018 San Diego, USA. 2nd International Conference on Cancer Biology and Drug Delivery October 03-04, 2018 Los Angeles, California, USA. International Conference on Gynecology and Obstetrics Pathology March 30-31, 2018 Orlando, USA.

4 . Organ Specific Cancer

Cancer is one of the major causes of death everywhere  in the planet. Organ Specific Cancers are cancers named according to the site of occurrence of cancer within the elements of the body. There are differint kinds of cancers, a number of them are Head and Neck Cancer, Brain cancer, carcinoma, oral cancer, liver disease, breast cancer, prostatic adenocarcinoma, gastric cancer, carcinoma, excretory organ (Renal Cell) cancer, leucaemia and Lung, prostate, colon, rectum, abdomen and liver ar the foremost common organs suffering from cancer in men. The foremost common organs suffering from cancer in females are breast, colon, rectum, lung, cervix and abdomen.

  • Brain and paranasal sinus cancer
  • Head and Neck cancer
  • Thyroid and Liver cancer
  • Pancreatic cancer
  • Breast and Cervical cancer
  • Thoracic and Lung cancer
  • Prostate cancer
  • Colorectal Cancer

Related Conferences AACR Annual Meeting 2018 April 14-18, 2018 McCormick Place, Chicago, USA. 5th Annual Meeting of the Japan Society of Clinical Oncology (JSCO) October 20 -22, Pacific Yokohama, JapanThe 76th Annual Meeting of the Japanese Cancer Associationhttps, September 28-30, Pacific Yokohama, Japan. 12th World Congress on Biomarkers & Clinical Research, October 03-04, 2018, Los Angeles, California, USA. 3rd Oncologist & Cancer Diagnostics Conference 2018, September 20-21, 2018 Berlin, Germany4th Annual Conference on Preventive Oncology July 18-19, 2018 Atlanta, USA. 27th International Conference on Cancer Research and Anticancer Therapies September 17-18, 2018 San Diego, USA. 2nd International Conference on Cancer Biology and Drug Delivery October 03-04, 2018 Los Angeles, California, USA. International Conference on Gynecology and Obstetrics Pathology March 30-31, 2018 Orlando, USA.

5 . Cancer Metastasis

Hematology- oncology is the branch of medicine associated with the study of diagnosing, treatment, and hindrance of blood diseases and cancer. It includes such diseases as iron deficiency anemia, hemophilia, red blood cell sickness, the Mediterranean anaemia, leukemias and lymphomas.The study of haematology integrates clinical and laboratory medication. Blood cancer affects your white blood cells. These are important, infection-fighting a part of your immune system, generated in your bone marrow. The cancerous formation moving the lymphocytes is termed as lymphoma. Lymphocytes square measure one in all the sorts of white blood corpuscles. As a part of metastatic tumor, the plasma is stricken by the cancer cells. Blood cancers can cause many different symptoms. Some are common across all blood cancers, others are additional characteristic of styles of blood cancer. For instance, body fluidomas are recognized by swollen lymph nodes and one in all the foremost common symptoms of metastatic tumor is bone pain, particularly within the back.

  • Pathophysiology
  • Organ-Specific Targets
  • Metastatic symptoms
  • Diagnosis and Management
  • Multimodal therapies

Related Conferences ASCO Annual Meeting 2018, June 1-5, 2018 McCormick Place, Chicago, USAAACR Annual Meeting 2018 April 14-18, 2018 McCormick Place, Chicago, USA. 5th Annual Meeting of the Japan Society of Clinical Oncology (JSCO) October 20 -22, Pacific Yokohama, JapanThe 76th Annual Meeting of the Japanese Cancer Associationhttps, September 28-30, Pacific Yokohama, Japan. 12th World Congress on Biomarkers & Clinical Research, October 03-04, 2018, Los Angeles, California, USA. 3rd Oncologist & Cancer Diagnostics Conference 2018, September 20-21, 2018 Berlin, Germany4th Annual Conference on Preventive Oncology July 18-19, 2018 Atlanta, USA. 27th International Conference on Cancer Research and Anticancer Therapies September 17-18, 2018 San Diego, USA. 2nd International Conference on Cancer Biology and Drug Delivery October 03-04, 2018 Los Angeles, California, USA. International Conference on Gynecology and Obstetrics Pathology March 30-31, 2018 Orlando, USA.

Breast cancer starts once cells within the breast initiate to grow out of management. These cells usually manifest a type of growth which will usually be felt as a lump. If the cells will grow into encompassing tissues or unfolding to distant areas of the body, the growth is malignant. The carcinoma which initiate within the ducts that carry milk to the tit is named ductal cancers. Some breast cancers begin within the glands that build breast milk is named lobe cancers. A variety of cancers begins in alternative tissues within the breast. These cancerous growths are known as sarcomas and lymphomas. Benign breast tumors area unit untypical growths, however they are doing not extent outside of the breast and that they don't seem to be aggressive. However some benign breast lumps will upsurge a woman's risk of obtaining carcinoma.

  • Ductal cancer
  • Lobular cancer
  • Sarcomas
  • Lymphomas
  • Benign breast cancer
  • Understanding breast cancer diagnosis
  • Breast reconstruction surgery
  • Advancements in breast cancer treatment

Related Conferences AACR Annual Meeting 2018 April 14-18, 2018 McCormick Place, Chicago, USA. 5th Annual Meeting of the Japan Society of Clinical Oncology (JSCO) October 20 -22, Pacific Yokohama, JapanThe 76th Annual Meeting of the Japanese Cancer Associationhttps, September 28-30, Pacific Yokohama, Japan. 12th World Congress on Biomarkers & Clinical Research, October 03-04, 2018, Los Angeles, California, USA. 3rd Oncologist & Cancer Diagnostics Conference 2018, September 20-21, 2018 Berlin, Germany4th Annual Conference on Preventive Oncology July 18-19, 2018 Atlanta, USA. 27th International Conference on Cancer Research and Anticancer Therapies September 17-18, 2018 San Diego, USA. 2nd International Conference on Cancer Biology and Drug Delivery October 03-04, 2018 Los Angeles, California, USA. International Conference on Gynecology and Obstetrics Pathology March 30-31, 2018 Orlando, USA.

Hematology Oncology is the branch of medicine related to the study of diagnosis, treatment, and prevention of blood diseases and cancer. It includes such diseases as iron deficiency anemia, hemophilia, sickle cell disease, the thalassemia, leukemias and lymphomas.The study of hematology integrates clinical and laboratory medicine. Leukemia affects your white blood cells. These are significant, infection-fighting part of your immune system, made in your bone marrow. The cancerous formation affecting the lymphocytes is known as lymphoma. Lymphocytes are one of the varieties of white blood corpuscles. As part of myeloma, the plasma (another variety of WBC) is affected by the cancer cells. Blood cancers can cause many different symptoms. Some are common across in blood cancers, others are more characteristic depending on the types of blood cancer. For example, lymphomas can be recognized by swollen lymph nodes and one of the most common symptoms of san diego  is bone pain, especially in the back.

  • Hematology
  • Lymphoma
  • Leukemia
  • Myeloma
  • Acute and Chronic blood cancer
  • Blood transfusion

Related Conferences 2nd World Congress on Nursing & Nurse Education, Nov 20 - 22, 2017, Miami, Florida, USA, EONS Leadership Summit, Sunday 19 November and Monday 20 November 2017, Cancer Care - Coming of Age Considerations for older people during and beyond cancer Creswick, VIC, November 24, 2017. 42nd Annual Conference and Exhibit, September 13-15, 2018, Savannah, GA. International Conference on Cancer Nursing (ICCN) 2018 will be held from September 23-26, 2018, Auckland New Zealand. 26th Annual Congress on Cancer Science and Therapy October 03-04, 2018 Los Angeles, California, USA. 4th Annual Conference on Preventive Oncology July 18-19, 2018 Atlanta, USA. 27th International Conference on Cancer Research and Anticancer Therapies September 17-18, 2018 San Diego, USA. 2nd International Conference on Cancer Biology and Drug Delivery October 03-04, 2018 Los Angeles, California, USA. International Conference on Gynecology and Obstetrics Pathology March 30-31, 2018 Orlando, USA.

8 . Skin Cancer

Skin cancers are cancers which develop from the skin. They are due to the progression of abnormal cells that can invade or spread to other parts of the body. Skin cancer is the most common form of cancer, globally accounting for at least 40% of cases. The most common type is non-melanoma skin cancer, which happens in at least 2-3 million people per year. There are three main types of skin cancers: basal-cell skin cancer (BCC), squamous-cell skin cancer (SCC) and melanoma. The lymphomas that start in the skin are called skin lymphoma. Surgical excision is the most common form of treatment for skin cancers. About 90 percent of nonmelanoma skin cancers are assisted with exposure to ultraviolet (UV) radiation from the sun. Sunscreen is effective and thus recommended to avert melanoma and squamous-cell carcinoma.

Related Conferences AACR Annual Meeting 2018 April 14-18, 2018 McCormick Place, Chicago, USA. 5th Annual Meeting of the Japan Society of Clinical Oncology (JSCO) October 20 -22, Pacific Yokohama, JapanThe 76th Annual Meeting of the Japanese Cancer Associationhttps, September 28-30, Pacific Yokohama, Japan. 12th World Congress on Biomarkers & Clinical Research, October 03-04, 2018, Los Angeles, California, USA. 3rd Oncologist & Cancer Diagnostics Conference 2018, September 20-21, 2018 Berlin, Germany4th Annual Conference on Preventive Oncology July 18-19, 2018 Atlanta, USA. 27th International Conference on Cancer Research and Anticancer Therapies September 17-18, 2018 San Diego, USA. 2nd International Conference on Cancer Biology and Drug Delivery October 03-04, 2018 Los Angeles, California, USA. International Conference on Gynecology and Obstetrics Pathology March 30-31, 2018 Orlando, USA

9 . Cancer Biomarkers

Biomarkers are molecules which indicate normal or abnormal processes occuring in your body. Biomarkers may be produced by the cancer tissue itself or by other cells in the body in response to cancer. It is especially used for the identification of breast cancer. They can be found in the blood, stool, urine, tumor tissue and body fluids. Cancer biomarkers can include Proteins, Gene mutations (changes), Gene rearrangements, Extra copies of genes, Missing genes and Other Molecules Biomarkers helps in cancer research to diagnose the early stage cancers, find out the aggressiveness and develop cancer drugs.

  • Diagnosis and Risk assessment
  • Prognosis and Treatment
  • Biomarkers in cancer research
  • Biomarkers in drug development

10 . Cancer Diagnosis and Screening

Screening tests can help to find cancer at an early stage, before recognizing the symptoms. When abnormal tissue or cancer is found early, it may be easier to treat or cure. The main aim of cancer screening is to reduce the mortality rate. Each type of cancer has its own screening test through which the pathologist can identify the precancerous or cancerous cells. Lung cancer is screened by using spiral computed tomography technique.  Mammography and Magnetic resonance imaging methods are used to screen the breast cancer. Human Papillomavirus testing and pap test are used to find out the cervical cancer. The techniques practiced to screen the colorectal cancer are colonoscopy, sigmoidoscopy and fecal occult blood test. Screening tests must be safe, well-tolerated and effective with appropriately low rates of false positive and false negative results. Screening has many risks such as over diagnosis, false positives, increased testing and false assurance.

  • Mammography
  • Colonoscopy
  • MUGA Scan
  • Barium Enema
  • Sigmoidoscopy
  • Tumor Marker Tests
  • Biopsy
  • Bone Marrow Aspiration and Biopsy
  • Computed Tomography (CT) Scan
  • Ultrasound
  • Upper Endoscopy
  • Digital Rectal Exam (DRE)
  • EKG and Echocardiogram
  • Types of Endoscopy
  • Fecal Occult Blood Tests
  • Magnetic Resonance Imaging (MRI)
  • Bone Scan
  • Breast MRI
  • Pap Test
  • Positron Emission Tomography and Computed Tomography (PET-CT) Scans
  • Benefits of screening
  • Risks of screening

11 . Chemotherapy

Chemotherapy is a type of cancer treatment which uses chemotherapeutic drugs to destroy the tumor cells. A doctor who specializes in treating cancer with medication, called a medical oncologist. The chemotherapy which is used before surgery or radiation to shrink a tumor is known as neoadjuvant chemotherapy and after surgery or radiation to kill any remaining cancer cell is known as adjuvant chemotherapy. In intravenous chemotherapy, chemotherapeutic agents are administered directly into vein to reach the tumor cells. Oral chemotherapy is usually taken in the form of a pill or capsule. Chemotherapeutic drugs are injected into an artery to treat the cancer is called intra-arterial chemotherapy (IA chemotherapy). Topical Chemotherapy is a cream or lotion applied directly to treat the skin cancer. When chemotherapeutic agents travel through the bloodstream to reach cells throughout the body, it is called systemic chemotherapy. When chemotherapeutic drugs are directed to a specific area of the body, it is called regional chemotherapy. These treatments cures many types of cancer effectively, but also cause different side effects.     

  • Chemotherapeutic drugs
  • Neoadjuvant and Adjuvant chemotherapy
  • Intravenous chemotherapy
  • Oral chemotherapy
  • Topical chemotherapy
  • Intra-arterial chemotherapy
  • Systemic and regional chemotherapy
  • Side effects of chemotherapy  

12 . Cancer Drugs

Cancer Drugs are used for treating cancer and relieving symptoms of the cancer (e.g. pain) and side effects, such as nausea. Doctors treat cancer with two or more chemotherapy drugs and sometimes with other medicines, such as steroids or biological therapies. Anti-cancer drugs destroy cancer cells by stopping development or multiplication at some point in their life cycles. Vaccines are medicines that increase the immune system's natural ability to protect the body against “foreign invaders” mainly infectious agents, which may cause disease. HPV vaccine and Hepatitis B vaccine are cancer prevention vaccines approved by the U.S.Food and Drug Administration (FDA). Cancer treatment vaccines are called therapeutic vaccines, which increase the ability of immune system to recognize and destroy the antigens.

  • Immunotherapy
  • Prophylactic vaccines
  • Cancer treatment vaccines
  • Clinical trials

13 . Anti-Cancer Drug Discovery & Therapy

Anti-cancer drug development is a major area of research. Around the world, tremendous resources are being invested in prevention, diagnosis, and treatment of cancer. Cancer is the second leading cause of death in Europe and North America. Discovery and improvement of anticancer agents are the key focus of numerous pharmaceutical companies as well as non-profit government and non-government organizations, like the National Cancer Institute (NCI) in the United States, the European Organization for Research and Treatment of Cancer (EORTC), and the British Cancer Research Campaign (CRC). Monitoring of response to newer anti-cancer drugs has undergone an evolution from structural imaging modalities to targeting functional metabolic activity at cellular level to better defined responsive and non-responsive cancerous tissue. Current challenges for anticancer drug development include the significant time and cost involvement, and the low success rates.

Related Conferences : International Kidney Cancer Symposium (USA), November 3-4, 2017, National Doral, Miami.

14 . Oncology Nursing Care

A nursing professional who specializes in caring for people with cancer is an Oncology nurse. They monitor physical conditions, prescribe medication, and administer chemotherapy and other treatments. Oncology is one of the most challenging and gratifying fields in nursing. The scope of oncology nursing extends from prevention and early stage diagnosis to treatment (such as surgical oncology, radiation oncology, medical oncology) through symptom management and palliative care. Oncology nurses have a cancer-specific knowledge base and clinical specialization in cancer.  Oncology nurses must inspect numerous details about each patient and they must tend to several patients each day. One mistake could affect a patient’s health, so their attention to detail is critical.

  • Palliative care
  • Symptom management
  • Oncology nursing education

Related Conferences 2nd World Congress on Nursing & Nurse Education, Nov 20 - 22, 2017, Miami, Florida, USA, EONS Leadership Summit, Sunday 19 November and Monday 20 November 2017, Cancer Care - Coming of Age Considerations for older people during and beyond cancer Creswick, VIC, November 24, 2017. 42nd Annual Conference and Exhibit, September 13-15, 2018, Savannah, GA. International Conference on Cancer Nursing (ICCN) 2018 will be held from September 23-26, 2018, Auckland New Zealand. 26th Annual Congress on Cancer Science and Therapy October 03-04, 2018 Los Angeles, California, USA. 4th Annual Conference on Preventive Oncology July 18-19, 2018 Atlanta, USA. 27th International Conference on Cancer Research and Anticancer Therapies September 17-18, 2018 San Diego, USA. 2nd International Conference on Cancer Biology and Drug Delivery October 03-04, 2018 Los Angeles, California, USA. International Conference on Gynecology and Obstetrics Pathology March 30-31, 2018 Orlando, USA.

15 . Cancer Epidemiology

The study of factors affecting cancer is known as cancer epidemiology. It helps to infer possible trends and causes. The study of cancer epidemiology uses epidemiological approaches to discover the cause of cancer and to classify and develop improved treatments. Observational epidemiological studies that show relation between risk factors and specific cancers mostly aid to generate hypotheses about potential interventions that could reduce morbidity or cancer incidence. Randomized controlled trials then test whether hypothesis generated by epidemiological studies and laboratory research result in reduced cancer incidence and mortality. In many instances, results from observational epidemiological studies are not confirmed by randomized controlled trials.

  • Randomized Controlled Trials
  • Observational epidemiological studies
  • Mortality and Morbidity
  • Risk Factors

Related Conferences AACR Annual Meeting 2018 April 14-18, 2018 McCormick Place, Chicago, USA. 5th Annual Meeting of the Japan Society of Clinical Oncology (JSCO) October 20 -22, Pacific Yokohama, JapanThe 76th Annual Meeting of the Japanese Cancer Associationhttps, September 28-30, Pacific Yokohama, Japan. 12th World Congress on Biomarkers & Clinical Research, October 03-04, 2018, Los Angeles, California, USA. 3rd Oncologist & Cancer Diagnostics Conference 2018, September 20-21, 2018 Berlin, Germany4th Annual Conference on Preventive Oncology July 18-19, 2018 Atlanta, USA. 27th International Conference on Cancer Research and Anticancer Therapies September 17-18, 2018 San Diego, USA. 2nd International Conference on Cancer Biology and Drug Delivery October 03-04, 2018 Los Angeles, California, USA. International Conference on Gynecology and Obstetrics Pathology March 30-31, 2018 Orlando, USA

16 . Cancer Epigenetics

The study of epigenetic modifications to the genome of cancer cells that do not include a change in the nucleotide sequence is known as Cancer Epigenetics. Epigenetic alterations are as important as genetic mutations in a cell's transformation to cancer and their manipulation embraces great potential for cancer prevention, detection, and therapy. A variety of compounds are considered as epigenetic carcinogens such as arsenite, diethylstilbestrol, hexachlorobenzene and nickel compounds. They result in an increased incidence of tumors, but they do not show mutagen activity.

  • DNA Methylation
  • Histone modification
  • MicroRNA gene silencing
  • Epigenetic carcinogens

Related Conferences ASCO Annual Meeting 2018, June 1-5, 2018 McCormick Place, Chicago, USAAACR Annual Meeting 2018 April 14-18, 2018 McCormick Place, Chicago, USA. 5th Annual Meeting of the Japan Society of Clinical Oncology (JSCO) October 20 -22, Pacific Yokohama, JapanThe 76th Annual Meeting of the Japanese Cancer Associationhttps, September 28-30, Pacific Yokohama, Japan. 12th World Congress on Biomarkers & Clinical Research, October 03-04, 2018, Los Angeles, California, USA. 3rd Oncologist & Cancer Diagnostics Conference 2018, September 20-21, 2018 Berlin, Germany4th Annual Conference on Preventive Oncology July 18-19, 2018 Atlanta, USA. 27th International Conference on Cancer Research and Anticancer Therapies September 17-18, 2018 San Diego, USA. 2nd International Conference on Cancer Biology and Drug Delivery October 03-04, 2018 Los Angeles, California, USA. International Conference on Gynecology and Obstetrics Pathology March 30-31, 2018 Orlando, USA.

17.Emergency Medicine

Adjuvant therapy: Treatment given after the main treatment to reduce the chance of cancer relapses by destroying any remaining cancer cells. It usually refers to chemotherapy, radiation therapy, hormone therapy, and/or immunotherapy given after surgery.

Bone marrow transplant: A medical procedure in which diseased bone marrow is replaced by healthy bone marrow from a volunteer donor. Learn more about bone marrow transplantation.

Chemotherapy: The use of drugs to kill cancer cells.

  • Radiation Therapy for Breast Cancer
  • Radiation Therapy for Gynecologic Cancer
  • Radiation Therapy for Cancer
  • Radiation Therapy for Melanoma

Clinical trial: A research study that tests new treatments or prevention methods to find out whether they are safe, effective, and possibly better than the current standard of care.

Complementary medicine: A diverse group of treatments, techniques and products that are used in addition to standard cancer treatments.

Hormone therapy: Treatment that removes, blocks, or adds hormones to destroy or slow the growth of cancer cells. It is also called hormonal therapy or endocrine therapy.

Integrative medicine: A combination of medical treatments for cancer and complementary therapies to help manage the symptoms and side effects of cancer.

Immunotherapy:  A type of cancer treatment designed to boost the body's natural defenses to fight the cancer. It uses materials made either by the body or in a laboratory to improve, target, or restore immune system function. It may also be called biologic therapy.

Neoadjuvant therapy: Treatment given before the main treatment. It may include chemotherapy, radiation therapy, or hormone therapy given before surgery to shrink a tumor so that it is easier to remove.

Palliative care: Palliative care is any form of treatment that concentrates on reducing a patient’s symptoms or treatment side effects, improving quality of life, and supporting patients and their families. It may also be called supportive care.

Placebo: An inactive drug or treatment in a clinical trial.

Protocol: A formal, written action plan for how a clinical trial will be carried out. It states the goals and timeline of the study, who is eligible to participate, what treatments and tests will be given and how often and what information will be gathered.

Radiation therapy: The use of high-energy x-rays or other particles to destroy cancer cells. The most common type of radiation treatment is called external-beam radiation therapy, which is radiation given from a machine outside the body. When radiation treatment is given using implants near the cancer cells, it is called internal radiation therapy or brachytherapy.

Regimen: A treatment plan that includes expected treatments and procedures, medications and their doses, the schedule of treatments and how long the treatment will last.

Standard of care: Care that experts agree or guidelines show is the most appropriate or effective for a specific type and stage of cancer.

Surgery: The removal of cancerous tissue from the body through an operation.

Targeted treatment: Treatment that targets specific genes, proteins, or other molecules that contribute to cancer growth and survival.

Oncology Conference Highlights:-

  • Surgical Oncology
  • Hematology and Oncology
  • Pediatric Hematology and Oncology
  • Gynecologic Oncology
  • Radiation Oncology
  • Clinical Radiation Oncology
  • Molecular Radiation Biology
  • Ductal Carcinoma
  • Gynecologic Cancers
  • Cervical Cancer
  • Endometrial Cancer
  • Ovarian Cancer
  • Peritoneal Cancer
  • Uterine Cancer
  • Vaginal Cancer
  • Vulvar Cancer
  • Acute lymphoblastic leukemia
  • Acute myeloid leukemia
  • Anal carcinoma
  • Bladder cancer
  • Bone cancer
  • Central nervous system cancers
  • Chronic Myelogenous Leukemia
  • Colon cancer
  • Rectal cancer
  • Esophageal and Esophagogastric junction
  • Gastric cancer
  • Hepatobiliary cancers
  • Hodgkin lymphoma
  • Kidney cancer
  • Malignant pleural mesothelioma
  • Melanoma
  • Multiple myeloma
  • Systemic light chain amyloidosis
  • Lymphoplasmacytic lymphoma
  • Myelodysplastic syndromes
  • Neuroendocrine tumors
  • Non-hodgkin’s lymphomas
  • Basal cell skin cancer
  • Dermatofibro Sarcoma Protuberans
  • Merkel cell carcinoma
  • Squamous cell skin cancer
  • Non-small cell lung cancer
  • Occult primary
  • Pancreatic adenocarcinoma
  • Penile cancer
  • Prostate cancer
  • Small cell lung cancer
  • Soft tissue sarcoma
  • Testicular cancer
  • Thymomas and Thymic carcinomas
  • Thyroid carcinoma
  • Uterine neoplasms
  • Chemotherapy
  • Hormonal therapy
  • Anti-angiogenesis therapies
  • Photodynamic therapy
  • Gene therapy

Related Conferences AACR Annual Meeting 2018 April 14-18, 2018 McCormick Place, Chicago, USA. 5th Annual Meeting of the Japan Society of Clinical Oncology (JSCO) October 20 -22, Pacific Yokohama, JapanThe 76th Annual Meeting of the Japanese Cancer Associationhttps, September 28-30, Pacific Yokohama, Japan. 12th World Congress on Biomarkers & Clinical Research, October 03-04, 2018, Los Angeles, California, USA. 3rd Oncologist & Cancer Diagnostics Conference 2018, September 20-21, 2018 Berlin, Germany4th Annual Conference on Preventive Oncology July 18-19, 2018 Atlanta, USA. 27th International Conference on Cancer Research and Anticancer Therapies September 17-18, 2018 San Diego, USA. 2nd International Conference on Cancer Biology and Drug Delivery October 03-04, 2018 Los Angeles, California, USA. International Conference on Gynecology and Obstetrics Pathology March 30-31, 2018 Orlando, USA.

 

Market Analysis

Oncogenesis 2018

Worldwide Oncology Drugs Market is expected to garner $111.9 billion by 2020, registering a CAGR of 7.1% during the forecast period 2014 to 2020. Recent progress in biological therapies has widened the scale of therapeutic targets for treatment of cancer with the identification of tumor cell specific genes. Biologics are emerging as potential therapies to find the permanent cure for various cancer types. Amongst various biologics, drugs based on monoclonal antibodies (mAbs) have gained significant attention in recent years due to their high efficacy

Recent progress in Biological Therapies

The global cancer drugs market provides oncological therapeutic products and services for patients. These drugs target the diseased cells in a body and reverse the cell proliferation that results in improvement of overall health conditions. The industry has witnessed substantial growth in terms of revenue and volume due to a rise in incidence rates and augmentation in types of cancer. At present, regulatory concerns, time-consuming clinical trials, and delayed approvals hinder the introduction of proposed drugs on consumer platforms.

However, the latest anti-cancer drugs developed with gene and protein mutations include erythropoietin drugs, biosimilar drugs, and nuclear medicine. The industry analysis encompasses portfolio offerings of renowned pharmaceutical companies in this segment. We also analyze the cost and pricing structures of anti-cancer drugs and their effect on growth patterns across geographies.

The market is driven by the increasing incidence of ovarian cancer. The need for more effective treatment options is pushing growth of the market. While the market is dominated by generics such as paclitaxel and carboplatin, it is expected that drugs such as Bevacizumab (Avastin), Pazopanib (Votrient) would boost the growth of this market. Development of drugs with improved efficacy is a challenge for this market. The opportunity for this market lies in developing new drugs for treating ovarian cancer.

International Cancer Drugs Market Analysis by Drug

The drugs used to treat ovarian cancer include Paclitaxel, Cisplatin, Adriamycin PFS (Doxorubicin Hydrochloride), Carboplatin, Cyclophosphamide, Platinol (Cisplatin), Paraplatin (Carboplatin), Doxorubicin Hydrochloride Liposome, Evacet (Doxorubicin Hydrochloride Liposome), Cytoxan (Cyclophosphamide), Paraplat (Carboplatin), Taxol (Paclitaxel), Neosar (Cyclophosphamide), Gemcitabine Hydrochloride, Platinol-AQ (Cisplatin), Topotecan Hydrochloride, Gemzar (Gemcitabine Hydrochloride), Hycamtin (Topotecan Hydrochloride), Doxorubicin Hydrochloride, LipoDox (Doxorubicin Hydrochloride Liposome), Dox-SL (Doxorubicin Hydrochloride Liposome), Clafen (Cyclophosphamide), Adriamycin RDF (Doxorubicin Hydrochloride), DOXIL (Doxorubicin Hydrochloride Liposome) and others. Treatment for ovarian cancer mostly includes a combination of two drugs, usually a platinum compound (Cisplatin or carboplatin) and a taxane (Paclitaxel or docetaxel).

Universal Cancer Drugs Market Analysis by Geography 

The market for ovarian cancer is segmented geographically into North America, Europe, Asia Pacific and LAMEA. North America is the major revenue generating market mainly due to the prevalence of ovarian cancer. According to the American Cancer Society, an estimated 21,980 women would be diagnosed with ovarian cancer in 2014 in the US. Europe is the second largest market as the incidence for ovarian cancer is high in Europe.

Competitive Analysis 

The companies include Roche, Amgen, Boehringer Ingelheim, GlaxoSmithKline, AstraZeneca and others. In Dec 2011, Roche received EU approval for the drug Avastin (bevacizumab) to be used in combination with carboplatin and paclitaxel as treatment for ovarian cancer.

High Level Analysis

Market analysis by porter’s five-force model shows that the bargaining power of the buyer is high in this market as the market is dominated by generic drugs and there are many suppliers producing the drugs. The threat of new entrants is moderate as the drugs for treating ovarian cancer are mainly generic and pharmaceutical companies can easily start producing the drugs. Intensity of rivalry is high in this market as competitors are numerous and the drugs are undifferentiated. Top impacting factors have been given to get a clearer understanding of the market.  

Key Benefits

  • In-depth analysis of the drugs in the market for treatment of ovarian cancer would help in understanding the capacity for growth in this market 
  • Segmentation by geography would help in identifying the demand for ovarian drugs in each region 
  • Key drivers and opportunities would help in a deeper understanding of the scope of the market
  • Porter’s five-force model would give a clear picture of the market and help in making business decisions
  • Estimations have been given for the period from 2013 to 2020, which would help in identifying the potential of the market

Key Deliverables

The  Cancer drug market is segmented by drugs and geography. 

By Drug

  • Paclitaxel
  • Cisplatin
  • Adriamycin PFS (Doxorubicin Hydrochloride)
  • Carboplatin
  • Cyclophosphamide
  • Platinol (Cisplatin)
  • Paraplatin (Carboplatin)
  • Doxorubicin Hydrochloride Liposome
  • Evacet (Doxorubicin Hydrochloride Liposome)
  • Cytoxan (Cyclophosphamide)
  • Paraplat (Carboplatin)
  • Taxol (Paclitaxel)
  • Neosar (Cyclophosphamide)
  • Gemcitabine Hydrochloride
  • Platinol-AQ (Cisplatin)
  • Topotecan Hydrochloride
  • Gemzar (Gemcitabine Hydrochloride)
  • Hycamtin (Topotecan Hydrochloride)
  • Doxorubicin Hydrochloride
  • LipoDox (Doxorubicin Hydrochloride Liposome)
  • Dox-SL (Doxorubicin Hydrochloride Liposome)
  • Clafen (Cyclophosphamide)
  • Adriamycin RDF (Doxorubicin Hydrochloride)
  • DOXIL (Doxorubicin Hydrochloride Liposome)

By Geography

  • North America
  • Europe
  • Asia Pacific 
  • LAMEA

Top Oncology Drugs:

Avastin, Alimta, Xeloda,Tarceva, Zometa, Sutent, Nexavar,Revlimid,Opdivo,Imbruvica

Keytruda,Ibrance,Tecentriq, Darzalex, Perjeta, Xtandi, Herceptin, Gazyva, Jakafi, Venclexta

Worldwide Societies Associated with Cancer !

  • American Cancer Society
  • American Association for Cancer Research
  • The Cancer Association of South Africa
  • National Cancer Society Malaysia
  • Kidney Cancer Association
  • Singapore Cancer Society
  • Cancer Association of Namibia
  • European Oncology Nursing Society
  • Oncology Nursing Society
  • International Society of Nurses in Cancer Care
  • Association of Pediatric Hematology/Oncology Nurses
  • Cancer Nurses Society of Australia

To Collaborate Scientific Professionals around the World

Conference Date September 17-18, 2018

For Sponsors & Exhibitors

sponsors@conferenceseries.com

Speaker Opportunity

Past Conference Report

Supported By

Journal of Cancer Science & Therapy Journal of Carcinogenesis & Mutagenesis Journal of Oncology Research and Treatment

All accepted abstracts will be published in respective Conferenceseries International Journals.

Abstracts will be provided with Digital Object Identifier by


Media partners & Collaborators & Sponsors

mediapartner

Media Partner

Keytopics

  • Acute Lymphoblastic Leukemia
  • Acute Myeloid Leukemia
  • Anal Carcinoma
  • Anti-angiogenesis Therapies
  • Basal Cell Skin Cancer
  • Bioethical Issues Oncology
  • Bladder Cancer
  • Bone Cancer
  • Bone Regeneration
  • Breast Tumour
  • Cancer Oncologists
  • Cancer Oncology Niche
  • Cellular Basis Of Growth
  • Cellular Oncogenes
  • Central Nervous System Cancers
  • Cervical Cancer
  • Chemotherapy
  • Chronic Myelogenous Leukemia
  • Clinical Applications Of Oncologys
  • Clinical Radiation Oncology
  • Colon Cancer
  • Computational Biology And Drug Designing
  • Current Research In Oncology And Molecular Biology
  • Dermatofibro Sarcoma Protuberans
  • Ductal Carcinoma
  • Endometrial Cancer
  • Ethics In Oncology Research
  • Gastric Cancer
  • Gene Expression Analysis
  • Gene Therapy
  • Germ Line Cells
  • Gynecologic Cancers
  • Gynecologic Oncology
  • Hematologists
  • Hematology And Oncology
  • Hepatobiliary Cancers
  • Hodgkin Lymphoma
  • Hormonal Therapy 
  • Immunomodulation
  • Kidney Cancer
  • Lymphoplasmacytic Lymphoma
  • Malignant Pleural Mesothelioma
  • Mast Cell Tumour
  • Melanoma
  • Merkel Cell Carcinoma
  • Molecular Radiation Biology
  • Multiple Myeloma
  • Myelodysplastic Syndromes
  • Nanotechnology: Oncologys & Cancer
  • Neuro Oncology
  • Neuro Oncology
  • Neuroendocrine Tumors
  • Neuroro Oncologists
  • Non-hodgkin’s Lymphomas
  • Occult Primary
  • Oncology And Molecular Medicine
  • Oncology And Therapeutics Europe
  • Oncology And Therapeutics Industry
  • Oncology Culture
  • Oncology Transplantation
  • Ovarian Cancer
  • Pancreatic Adenocarcinoma
  • Pediatric Hematology And Oncology
  • Penile Cancer
  • Peritoneal Cancer
  • Photodynamic Therapy
  • Prostate Cancer
  • Radiation Oncology
  • Rectal Cancer
  • Rediologists
  • Small Cell Lung Cancer
  • Soft Tissue Sarcoma
  • Somatic Cloning
  • Squamous Cell Skin Cancer
  • Surgical Oncology
  • Systemic Light Chain Amyloidosis
  • Testicular Cancer
  • Thymomas And Thymic Carcinomas
  • Thyroid Carcinoma
  • Tissue Engineering
  • Tumour Lysis
  • Uterine Cancer
  • Uterine Neoplasms
  • Vaginal Cancer
  • Vulvar Cancer